Other
Induction of Labor
0
Pipeline Programs↗
9
Active Trials↗
1
Companies Involved↗
Induction of Labor is an early-stage landscape with 0 programs across 1 company. The most active players are Novartis.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
63
clinical trials
Completed32 · 51%
Unknown status20 · 32%
Recruiting5 · 8%
Not yet recruiting2 · 3%
Terminated2 · 3%
Active, not recruiting2 · 3%
Clinical Trials
Trial Activity
63 trials
Cervical Sliding Sign to Predict Outcome of Induction of Labor
Active, not recruiting·—·N/A·NCT06324279·130 enrolled
Effectiveness of Evening Primrose Oil for Induction of Labor
Not yet recruiting·—·Phase 1·NCT06539975·72 enrolled
Induction of Labor by Oral Misoprostol Solution
Completed·—·N/A·NCT04891679·264 enrolled
Comparison of Outcome of Foley Catheter Versus Misoprostol for Induction of Labor
Completed·—·N/A·NCT07416487·76 enrolled
Prostin and Propess in Induction of Labor
Completed·—·Phase 3·NCT01635439·200 enrolled
Combined Foley Catheter Balloon and PGE2 Vaginal Ovule for Induction of Labor at Term: A Randomized Study
Completed·ZZeynep Kamil Maternity and Pediatric Research and Training Hospital·Phase 2·NCT02861079·300 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)